Shows
MS-Perspektive - der Multiple Sklerose PodcastWie Erfahrungsdaten aus der Versorgung die MS-Behandlung verändern – Erkenntnisse vom ECTRIMS 2025In dieser Episode geht es darum, wie Real-World-Daten in der MS-Behandlung Therapieentscheidungen verändern. Ich stelle dir sieben aktuelle Studien vom ECTRIMS 2025 vor: Dr. Susanna Hallberg zeigt, wie häufig späte Neutropenie unter Rituximab auftritt und welche Risikofaktoren eine Rolle spielen. Dr. Yao Zhang identifiziert Faktoren für schwere Infektionen unter Ocrelizumab (z. B. Alter 50+, frühere Infektionen). Dr. Dominika Stastná belegt, dass eine frühzeitige hochwirksame Therapie das Risiko für Behinderungszunahme deutlich senkt. Dr. Giulio Disanto untersucht Gedächtnis-B-Zellen und verlängerte Ocrelizumab-Intervalle. Dr. Helly Hammer berichtet...
2025-12-1141 min
MS-Perspektive - der Multiple Sklerose PodcastMS-Symptome und ihr Management. Was neue Forschung für Betroffene bedeutet. Ein ECTRIMS 2025 SpezialIn dieser ECTRIMS-2025-Spezialfolge tauchen wir tief in vier neue Studien ein, die zeigen, wie vielfältig und vielschichtig MS-Symptome im Alltag wirken – und wie Forschung Menschen mit MS gezielt unterstützen kann. Die Vorträge widmeten sich kognitiver Gesundheit, patientenberichteten Ergebnissen (PROMs), den Gründen für vorzeitigen Ruhestand und den Trends beim Zugang zu symptomatischen Behandlungen in Frankreich. Du erfährst unter anderem: • warum geistig anregende Aktivitäten die kognitive Reserve stärken können, • wie PROMs helfen, Verschlechterungen früher zu erkennen, • welche Symptome am stärksten mit Frühverrentung zusammenhängen, • warum v...
2025-11-2419 min
BeewellwithMS podcast by Dr Agne StraukieneAdvancements in MS Treatments 2025 ECTRIMSJoin Dr. Agne Straukiene, a neurologist specialising in Multiple Sclerosis, as she unveils groundbreaking treatments discussed at the ECTRIMS 2025 conference. Discover how BTK inhibitors like #Tolebrutinib, #Evobrutinib, #Orelabrutinib, #Remibrutinib, and #Fenebrutinib could revolutionize MS care by targeting both B cells and brain cells to reduce inflammation and progression. Learn about #Frexalimab's novel mechanism and promising trial results, the potential of combining #Clemastine and #Metformin for myelin repair, and remarkable long-term outcomes of autologous haematopoietic stem cell transplantation. Explore the exciting advent of #CART cell therapy poised to change the future of MS treatment.00:00 Introduction to MS and ECTRIMS 2025
2025-11-1209 min
MS-Perspektive - The Multiple Sclerosis PodcastHow Real-World Evidence Is Shaping the Future of Multiple Sclerosis Treatment – Highlights from ECTRIMS 2025In this episode, I take you behind the scenes of ECTRIMS 2025 and explore seven fascinating studies that show how multiple sclerosis (MS) care is evolving — from safety monitoring and infection risks to data-driven, personalized treatment decisions. You'll learn about: How often late-onset neutropenia occurs in people on Rituximab and who's most at risk. What factors increase the chance of serious infections with Ocrelizumab. Why early high-efficacy treatment leads to better long-term outcomes across four countries. What happens to memory B cells during long-term Ocrelizumab therapy and what that means fo...
2025-11-1238 min
The MS Trust podcastECTRIMS Patient Community Day: why researchers need people with MS to get involvedSend us a message about the podcast. For questions about MS please contact our helpline 0800 032 38 39In this episode we explore the biggest breakthroughs from ECTRIMS 2025, the world’s largest MS research conference. We look into new treatment insights, the push for inclusive research, and how people with MS can shape the future of care.Featuring Brett Drummond from MS translate, Natalie Busari from The Nerve of My MS, Dr. Claire Winchester research and engagement, at MS Trust , and Lucy Taylor our MS Trust CEOEpisode notesEC...
2025-10-281h 09
The Raw NerveEp69 ECTRIMS 2025: Shaping the next frontier of MS researchIn today’s episode, MS Australia Deputy CEO, Dr Julia Morahan and Head of Research, Dr Tennille Luker report on and unpack ECTRIMS 2025 – the world’s largest MS treatment and research congress. The recent event attracted over 9000 international delegates and serves as a crucial platform for researchers, clinicians and healthcare providers to collaborate on, explore and advance novel life-changing research and treatment options for people with MS.Julia and Tennille contextualise and share their perspectives on the most exciting developments, clinical trials, BTK (Bruton's tyrosine kinase) inhibitors, updated diagnostic criteria and more, presented at ECTRIMS 2025 under the theme of ‘...
2025-10-2728 min
MS-Perspektive - The Multiple Sclerosis Podcast#137: Innovative MS Rehabilitation Approaches – Insights from ECTRIMS 2025In this episode, we dive into five innovative rehabilitation studies presented at ECTRIMS 2025. From the validation of digital assessments to family-centered care and home-based rehabilitation, these studies offer promising insights for people living with MS. Whether you're a patient, caregiver, or healthcare professional, this episode highlights tools and approaches that can improve quality of life, independence, and symptom management. 📰 Prefer reading instead? 👉 Check out the full blog article with all study summaries here: https://ms-perspektive.com/137-rehab-ectrims 🧠 Poster Summaries 1. Robot-based assessment of motor-cognitive dual-task abilities in unimpaired adults Authors: E. Misley et al. Summary: This study val...
2025-10-2214 min
RealTalk MSThe ECTRIMS 2025 Deep Dive with Dr. Bruce BeboJust about a month ago, 9,600 researchers, clinicians, and representatives from patient advocacy organizations gathered in Barcelona for the European Committee on Treatment and Research in MS annual scientific congress, better known as ECTRIMS, the largest MS research conference in the world. Now that he's had an opportunity to review his notes and digest all of the science presented at ECTRIMS 2025, Dr. Bruce Bebo, the National MS Society's Executive Vice-President of Research, returns to the podcast to take us on a deep dive covering some of the most important research presented this year. We're...
2025-10-2133 min
MS-Perspektive - der Multiple Sklerose Podcast11. MS-Kamingespräch zum ECTRIMS 2025Beim 11. MS-Kamingespräch sprechen Nadja und ich über unsere Eindrücke vom ECTRIMS 2025 in Barcelona – dem größten internationalen MS-Kongress. Im Mittelpunkt stehen neue Erkenntnisse zu Kognition, Ernährung, digitalen Technologien und Therapieansätzen, aber auch persönliche Eindrücke, Lebensfreude und Hoffnung. Zwei Perspektiven – online und vor Ort – zeigen, wie viel Bewegung in der MS-Forschung steckt und wie ganzheitlich der Mensch heute gesehen wird. Hier kannst Du die Zusammenfassung gern Nachlesen: https://ms-perspektive.de/327-ms-kamingespraech Behandelte Themen: Eindrücke vom ECTRIMS 2025 in Barcelona Forschung zu Kognition & Fatigue Ernährung und...
2025-10-2044 min
MS-Perspektive - The Multiple Sclerosis PodcastCognitive Rehabilitation in MS – From Research to Everyday Relevance. An ECTRIMS 2025 SpecialIn this episode, I explore five exciting studies from ECTRIMS 2025 that reveal how cognitive training, mindfulness, and smart rehab planning can support brain function and independence in people with MS. You can read the text version here: https://ms-perspektive.com/136-cognitive-rehab Cognitive changes affect a large percentage of people with multiple sclerosis—yet they often remain invisible or unspoken. This episode focuses on new, science-backed strategies to strengthen thinking skills, reduce stress, and even promote brain reorganization. 🧠 What's inside: I highlight 5 research posters presented at ECTRIMS 2025: Digital brain training boost...
2025-10-1516 min
MS-Perspektive - der Multiple Sklerose Podcast#325: Kognition und MS beim ECTRIMS. Den geistigen Leistungsrückgang verstehen und damit umgehenIn dieser Solo-Episode teile ich die wichtigsten Erkenntnisse der ECTRIMS 2025 Lecture von Prof. Maria Pia Amato zur Kognition bei Multipler Sklerose. Kognitive Veränderungen gehören zu den häufigsten, aber oft übersehenen Symptomen bei MS. Sie betreffen Konzentration, Gedächtnis, Sprache und Entscheidungsfähigkeit – und können in jedem Krankheitsstadium auftreten. Du erfährst: Warum Kognition bei MS so wichtig ist Welche kognitiven Bereiche betroffen sein können Wie man Beeinträchtigungen frühzeitig erkennt und misst Welche Rolle kognitive Reserve und Lebensstil spielen Welche Behand...
2025-10-0623 min
NeurologyLive® Mind Moments®ECTRIMS 2025 Debrief: Precision MS & What’s Next with Daniel OntanedaWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, "ECTRIMS 2025 Meeting Highlights and Clinical Takeaways," Daniel Ontaneda, MD, PhD, neurologist at Cleveland Clinic’s Mellen Center for MS, shared his reflections from the 2025 ECTRIMS Congress, held September 24-26, in Barcelona, Spain. He discussed the significance of the updated MS diagnostic criteria, which generated immediate research applications and clinician discussion early in the meeting. Ontaneda also highlighted the growing emphasis on precision medicine and individualized treatment approaches, including extended-interval dosing strategies for B-ce...
2025-10-0319 minBeewellwithMS podcast by Dr Agne StraukieneKey Highlights from ECTRIMS 2025: Advances in Multiple Sclerosis ResearchWelcome to BeeWellWithMS! Dr. Agne, MS Neurologist, shares key insights from ECTRIMS 2025, held in Barcelona. The event marks a new era of precision in MS care with advancements in MRI, AI tools, and lifestyle research. Discover how new lesion types can signal brain inflammation earlier, understand the impact of aging on MS, and explore the latest in treatment options including stem cell therapy and high-dose vitamin D3. Learn how personalised care and lifestyle adjustments, like diet changes, can support brain health and MS symptom management. Stay informed and proactive in your MS journey—Bee Well!00:00 Introduction to ECTRIMS 2025 Hig...
2025-10-0303 min
DyNAMICS HighlightsEP 44 - Novità dal congresso ECTRIMS 2025 - Diana FerraroDurante il congresso ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), tenutosi a Barcellona tra il 24 e 26 settembre 2024, sono stati portati dati sull'impatto nella pratica clinica dell'applicazione dei nuovi criteri diagnostici per la Sclerosi Multipla del 2024. L'applicazione dei nuovi criteri permette di effettuare una diagnosi di Sclerosi Multipla in una proporzione maggiore di pazienti già all'esordio (es. 71% versus il 47% dei precedenti criteri in una casistica di 326 pazienti - presentazione di Luca Bollo, Barcellona) grazie all'utilizzo di una serie di strumenti paraclinici comprensivi di Risonanza Magnetica, Potenziali Evocati Visivi, OCT e kappa index. Tra questi, il kappa index, come a...
2025-10-0208 min
MS-Perspektive - The Multiple Sclerosis Podcast#134: Cognition and MS at ECTRIMS: Understanding and Managing Cognitive DeclineIn this solo episode from ECTRIMS 2023, I share the highlights from the inspiring lecture by Prof. Maria Pia Amato on cognition and multiple sclerosis. Cognitive changes are common in MS and affect nearly half of all patients – from attention and memory to language and executive function. You will learn: How cognitive impairment appears across the MS spectrum (including CIS, RIS, pediatric MS, and aging). Why regular cognitive screening matters and which tools are recommended. Insights into the underlying mechanisms of cognitive decline. The role of cognitive reserve and lifestyle in...
2025-10-0136 min
RealTalk MSFrom ECTRIMS 2025 with Dr. Bruce Bebo and Kristine Werner OzugLast week, over 9600 MS researchers and clinicians gathered in Barcelona for the European Committee for Treatment and Research in Multiple Sclerosis annual scientific congress -- ECTRIMS 2025. Minutes after the conference adjourned, in what has become an annual tradition, Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, joined me to share his initial thoughts on the science presented at the meeting. Then, Kristine Werner Ozug, a member of the RealTalk MS team who lives with MS, joined me to share her perspective on three non-stop days of presentations...
2025-09-3023 min
MS-Perspektive - der Multiple Sklerose Podcast#324: ECTRIMS 2025: Erste Einblicke für MS-Patient:innenECTRIMS ist der weltweit größte MS-Kongress und findet 2025 in Barcelona statt. Tausende Forschende und Ärzt:innen teilen hier die neuesten Erkenntnisse zur Multiplen Sklerose. In dieser Folge gebe ich einen Überblick über die ersten Highlights aus den Pressemitteilungen: Frühe Biomarker für das stille Fortschreiten (PIRA) Welche Rolle die Menopause bei MS spielen könnte Ernährung: Zusammenhang zwischen ultraverarbeiteten Lebensmitteln und Krankheitsaktivität Umwelteinflüsse: Ozonbelastung und Risiko für pädiatrische MS Ocrelizumab: starke Wirkung gegen Schübe – aber Grenzen beim Fortschreiten 🔗 Referenzen (Abstracts ECTRIMS 2...
2025-09-2912 min
MS TalkMS Talk: ECTRIMS 202526 september 2025.Deze week is het weer tijd voor de Ectrims: het grootste wereldwijde congres over MS voor MS behandelaren.Wat wordt er dit jaar besproken? Wie komen er eigenlijk op zo'n congres en waarom gaat de fysiotherapeut, ergotherapeut en de diëtist in de toekomst een veel grotere rol spelen bij de behandeling van mensen met MS? En wellicht de belangrijkste vraag: wat zijn de nieuwste inzichten en ontwikkelingen?In deze aflevering spreekt Nanda Felderhof met Gerald Hengstman in Barcelona terwijl de ECTRIMS nog bezig zijn! Je hoort hier dus het laatste nieuws al eerst!Let op: Vanwege de v...
2025-09-2625 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2025 Neuro News aus Barcelona, Folge 2 | Nervennahrung Podcast
Neuro News Update: An Tag 2 diskutieren Herr Prof. Tobias Ruck und Herr Prof. Mathias Mäurer über die Highlights des zweiten Tages vom ECTRIMS 2025 in Barcelona.
Diese Aufzeichnung stammt vom 25.09.2025. Morgen gibt es ein neues Update vom ECTRIMS aus Barcelona.
Produzent: Patrick Aust
Unser Archiv sowie weitere Episoden des Nervennahrung Podcasts finden Sie zudem unter: https://fachportal.roche.de/services/podcasts/nervennahrung-fuer-neurologen.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen also keineswegs einen Arztkontakt, wenn es um di...
2025-09-2516 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2025 MS Highlights: First Insights for PatientsRead the full blog article here: ms-perspektive.com – ECTRIMS 2025 MS Highlights ECTRIMS 2025 MS Highlights: First Insights for Patients ECTRIMS is the world's largest MS conference, and in 2025 it takes place in Barcelona. Thousands of researchers and clinicians share the newest findings on multiple sclerosis. In this episode, we look at the first highlights from the press releases: Early biomarkers for silent progression (PIRA) How menopause may influence MS and comorbidities The role of ultra-processed foods in relapses and MRI lesions Environmental risk: pediatric ozone exposure Oc...
2025-09-2509 min
The ECTRIMS PodcastDay 1 Highlights of ECTRIMS 2025The 41st Congress of ECTRIMS opened in Barcelona with Professor Maria Pia Amato of the University of Florence delivering the ECTRIMS Lecture. In this conversation with host Brett Drummond, she highlights the key takeaways from Day One of ECTRIMS 2025 and shares insights on cognition and what's shaping the future of multiple sclerosis research and care.
2025-09-2423 min
MS-Perspektive - The Multiple Sclerosis PodcastNew Research for Managing Primary Progressive Multiple Sclerosis (PPMS) an ECTRIMS SpecialLatest treatments and research presented at ECTRIMS 2024 for managing primary progressive MS (PPMS). including innovative therapies like CAR T-cell therapy. You can read the full article on my blog: https://ms-perspektive.com/098-ppms-ectrims Primary Progressive Multiple Sclerosis (PPMS) presents unique challenges, as it often worsens without relapses and can significantly impact daily life. However, the growing body of research and treatment options is providing new hope for managing this condition. From exploring the effectiveness of established therapies like Ocrelizumab to cutting-edge advancements in CAR T-cell treatments, scientists and healthcare providers are uncovering ways to slow...
2025-01-2931 min
RealTalk MSEpisode 383: Revisiting ECTRIMS 2024 with Dr. Bruce Bebo and Kristine Werner OzugOne of the most important MS research events every year is the annual European Committee for Treatment and Research in MS Scientific Congress, usually referred to by its acronym, ECTRIMS. You've made our podcast episode that followed ECTRIMS the most downloaded episode of the year. So, this week, I'm revisiting the two conversations that I had immediately after the ECTRIMS conference ended. In what has become an annual tradition, it's my privilege to sit down with the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, just minutes after the conclusion of ECTRIMS to get his first...
2024-12-3128 min
The ECTRIMS PodcastAdvancing MS Knowledge through the ECTRIMS FellowshipThe recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTranslate about the research projects that they will be pursuing and how they believe this opportunity will impact their career. The ECTRIMS Fellowship application period for the 2025 cycle is now open. Apply before the deadline of December 1, 2024 at 23:59 CET.
2024-12-2316 min
RealTalk MSECTRIMS Research Roundup Part 2 with Dr. Bruce BeboNow that he's had a chance to digest all of the research presented at ECTRIMS, Dr. Bruce Bebo, the National MS Society's Executive Vice President of Research, is back to share the key research presented at the largest MS research conference in the world. This episode of RealTalk MS is the perfect follow-up to my initial conversation with Bruce, which occurred just minutes after ECTRIMS ended. (If you missed our conversation, you may want to check out Episode 369 of RealTalk MS.) We have a lot to talk about! Are you ready for RealTalk MS??!
2024-10-2227 min
MS-Perspektive - der Multiple Sklerose Podcast7. MS-Kamingespräch zum ECTRIMS 2024 und Patient Community DayNadja berichtet von ihren Live-Eindrücken vom ECTRIMS und Patient Community Day in m Zwiegespräch mit Nele, die digital teilgenommen hat. Du kannst das Interview auf meinem Blog Nachlesen: https://ms-perspektive.de/ms-kamingespraech-ectrims-2024 Diesmal dreht sich alles um die neuesten Eindrücke und Erkenntnisse von der ECTRIMS-Konferenz 2024, vor allem dem Patient Day. Nadja war live vor Ort in Kopenhagen, während ich die Veranstaltung online mitverfolgt habe. Gemeinsam sprechen wir über einige spannende Paper und Präsentationen, darunter die neuen McDonald's-Kriterien zur MS-Diagnose und interessante Studienergebnisse. Besonders im Fokus steht der Patient Commun...
2024-10-1838 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS Spezial: Deeskalieren und Absetzen von Therapien bei MS – Was bedeutet das und wie kann es funktionieren?Wann kann man über das Deeskalieren oder gar Absetzen einer hochwirksamen Immuntherapie nachdenken und was gilt es dabei zu beachten? Die schriftliche Version zum Nachlesen gibt es auf meinem Blog: https://ms-perspektive.de/ectrims-deeskalieren Hallo und willkommen zu einer weiteren Zusammenfassung vom ECTRIMS 2024, in der es diesmal um das Deeskalieren und das Absetzen der Therapie geht. Dazu gab es sowohl eine wissenschaftliche Vortragsreihe mit sechs Vorträgen, die von Dr. Melinda Magyari und Prof. Bernhard Hemmer moderiert wurde. Und außerdem noch einzelne Poster. Abgesehen von einer Arbeit über NMOSD und MOGAD beschäfti
2024-10-1735 min
RealTalk MSECTRIMS Extra: Results from the Tolebrutinib Phase 3 Clinical Trial for Relapsing MS with Dr. Jiwon Oh With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh. Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital in Ontario, Canada. Dr. Oh is also the Principal Investigator in G...
2024-10-0408 min
RealTalk MSECTRIMS Extra: Revisions to the Way MS is Diagnosed with Dr. Peter Calabresi With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Peter Calabresi. Dr. Peter Calabresi is the Director of the Division of Neuroimmunology and the Director of the Multiple Sclerosis Center at Johns Hopkins Medicine. He is the principal investigator on several clinical t...
2024-09-2809 min
RealTalk MSECTRIMS Extra: Rachel Horne and Professor Kerstin Helwig With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Rachel Horne and Professor Kerstin Hellwig. Professor Kerstin Hellwig is the 2024 recipient of the Rachel Horne Prize for Women's Research in MS. Professor Hellwig was honored at ECTRIMS for her pioneering research into understanding a...
2024-09-2611 min
RealTalk MSECTRIMS 2024 with Kristine Werner Ozug and Dr. Bruce BeboECTRIMS 2024, the largest MS research conference in the world concluded last week, and in this week's episode, we'll be hearing two slightly different perspectives on which news, announcements, and presentations stood out at this year's meeting. The ECTRIMS conference can feel almost overwhelming. You find yourself among 9 or 10 thousand other attendees, trying to determine which of the more than 1700 scientific presentations you want to learn more about. It's both a marathon and a sprint that seem to be taking place simultaneously. Kristine Werner Ozug is a member of the RealTalk MS team and a person...
2024-09-2430 min
RealTalk MSECTRIMS EXTRA: New Course Descriptors for MS with Dr. Fred LublinWith more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Fred Lublin. Dr. Fred Lublin is the Director of the Corrine Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. He participated in the development of the very first disease-modifying therapy that was...
2024-09-2107 min
The ECTRIMS PodcastDay 3 Highlights of ECTRIMS 2024Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.
2024-09-2021 min
MS TalkEctrims 2024
BREAKING NEWS!
Vandaag, 20 september 2024, is de laatste dag van de Ectrims in Kopenhagen; hèt wereldwijde congres voor neurologen met betrekking tot MS. Met de grootste doorbraak op MS gebied hebben ze tot de laatste dag gewacht. Een doorbraak die wellicht een verandering gaat betekenen in de behandeling van de ziekte MS.
Vanaf het vliegveld in Kopenhagen vertelt Gerald Hengstman aan Nanda Felderhof wat hij heeft gehoord deze laatste dag en wat er over deze ontdekking bekend is en wat dit mogelijk gaat betekenen in de MS wereld.
Onze excuses voor de verminderde geluidskwaliteit van deze aflevering, we wilden d...
2024-09-2017 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2024 – Personalisierte MS-Behandlungen, genetische Risikofaktoren und Vorteile früher, wirksamer Therapien für Frauen und KinderPersonalisierte Behandlungen, genetische Risikofaktoren, geschlechtsspezifische Unterschiede und Vorteile früher, hochwirksamer Therapien. Hier kannst du den kompletten Beitrag nachlesen: https://ms-perspektive.de/ectrims-2024-1 Dieses Jahr kommen auf der ECTRIMS 2024 in Kopenhagen, Dänemark, wieder führende Experten für Multiple Sklerose (MS) aus der ganzen Welt zusammen. Die renommierte Konferenz ist die wichtigste Veranstaltung für Forscher, Ärzte und medizinisches Fachpersonal, die alle auf ein gemeinsames Ziel hinarbeiten: die Verbesserung der Lebensqualität durch bahnbrechende Forschung und Fortschritte bei der Behandlung von MS und verwandten Krankheiten. Die Veranstaltung, zu der rund 9.000 Teilnehmer erwartet werden, verspri...
2024-09-1922 min
MS-Perspektive - The Multiple Sclerosis PodcastSpecial: ECTRIMS 2024 - Personalized MS treatments, genetic risk factors and the benefits of early, effective therapies for women and childrenPersonalized treatments, genetic risk factors, gender differences and the advantages of early, highly effective therapies. You can read the full article here: https://ms-perspektive.com/ectrims-2024-ww1 This year, ECTRIMS 2024 in Copenhagen, Denmark, will once again bring together leading experts in multiple sclerosis (MS) from around the world. The prestigious conference is the premier event for researchers, physicians and healthcare professionals all working towards a common goal: improving quality of life through groundbreaking research and advances in the treatment of MS and related diseases. The event, which is expected to attract around 9,000 attendees, promises a...
2024-09-1919 min
The ECTRIMS PodcastDay 1 Highlights of ECTRIMS 2024ECTRIMS Vice President Bruno Stankoff highlights the most relevant insights from day one of ECTRIMS 2024 in Copenhagen, and provides a glimpse of what to expect from the ECTRIMS society in the coming year.
2024-09-1819 min
The ECTRIMS PodcastPre-Day Highlights of ECTRIMS 2024Listen to Romain Marignier from CHU de Lyon and host Brett Drummond discuss highlights of ECTRIMS' new Pre-Day on NMOSD, MOGAD, and other rare neurological conditions.
2024-09-1717 minThe Raw NerveEp40 ECTRIMS 2024: Shaping the future of MS researchIn the latest episode of the Raw Nerve recorded on Friday 13 September, guests Julia Morahan and Heidi Beadnall sit down with the CEO of MS Australia to dive deep into the highlights of the upcoming ECTRIMS 2024 (18-20 September) – the world’s largest MS research congress. The event, attracting over 10,000 delegates from around the globe, serves as a crucial platform for researchers, clinicians, and healthcare professionals to explore and advance the latest in MS research and treatment.
Join the discussion as they explore the revised McDonald Criteria, which bring updated diagnostic guidelines for MS, enhancing early diagnosis and tailo...
2024-09-1627 min
The ECTRIMS PodcastECTRIMS-EAN Vaccination Consensus Statement (eanCast)The following episode has been produced by the European Academy of Neurology (EAN) in collaboration with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), and has been published on both the EAN and ECTRIMS Podcast channels to ensure our joint communities have access to it. In this episode of eanCast: Weekly Neurology, host Melinda Magyari is joined by ECTRIMS Podcast host Brett Drummond to talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero of the Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain and the Multiple Sclerosis...
2024-09-0433 min
eanCast: Weekly NeurologyEp. 111: ECTRIMS-EAN Vaccination Consensus StatementEAN Moderator: Melinda Magyari (Copenhagen, Denmark)
Special Moderator: Brett Drummond (Melbourne, Australia)
Guest: Susana Otero (Barcelona, Spain)
In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Br
EAN Moderator: Melinda Magyari (Copenhagen, Denmark)Special Moderator: Brett Drummond (Melbourne, Australia)Guest: Susana Otero (Barcelona, Spain)In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.
2024-09-0232 min
NeuroFrontiersKey Highlights from ECTRIMS 2024
Guest: Mar Tintore, MD
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting is celebrating its 40th anniversary in Copenhagen, Denmark. 9,000 delegates from all over the world are expected to attend this multiday event, which will include keynote lectures, poster sessions, and selected scientific and educational sessions, as well as plenty of philanthropic and networking opportunities and more. Tune in for a brief overview with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.
2024-08-0202 minNeuroFrontiersThe Impact of ECTRIMS Over 40 Years
Guest: Mar Tintore, MD
A special guest will be joining the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting on opening day. To learn more about the impact ECTRIMS has had on multiple sclerosis patients over the last 40 years, tune in with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.
2024-08-0202 min
Esclerosis en la OndaNeuróloga Patricia Mulero en ECTRIMSEn el programa de hoy nuestra neuróloga de referencia nos cuenta su experiencia como asistente en la 9ª edición del ECTRIMS del pasado mes de octubre en Milán.
2024-01-0834 min
Esclerosis en la OndaECTRIMS con la neuróloga Patricia MuleroEn el programa de hoy nuestra neuróloga de referencia nos cuenta su experiencia como asistente en la 9ª edición del ECTRIMS del pasado mes de octubre en Milán.
2024-01-0834 min
Klinisch Relevant PodcastECTRIMS 2023: Take Home Messages - mit PD Dr. med. Marc PawlitzkiImpfung, BTK-Inhibitoren und mehr..
Pawlitzki, M. (2023, 7. November), ECTRIMS 2023: Take Home messages [Audio-Podcast] in Klinisch Relevant Podcast
Link:
https://open.spotify.com/episode/41OaheyyqGNl80K78SBc45?si=92yCiyOjQ5CgGe_lgblVuw
Der ECTRIMS-Kongress hat in der MS-Fachwelt einen hohen Stellenwert und gehört zu den wichtigsten Veranstaltungen des Jahres.
Marc Pawlitzki, Oberarzt und Leiter der MS-Ambulanz an der Uniklinik Düsseldorf, war vor Ort und teilt mit Euch in diesem Podcast seine Take Home messages.
Zwar hat es die erhofften Studienergebnisse zu den BTK-Inhibitoren noch nicht gegeben, dennoch gab es aus Marcs Sicht wichtige Forschungsergebnisse und Themen: MS...
2023-11-0719 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2023. Tag 3. Pädiatrische MS. Frauengesundheit. Prodromale MS. Stammzelltherapie bei MS.Überblick zu den Vorträgen über pädiatrische MS, Frauengesundheit bei MS, der prodromalen MS und Erfahrungen zur Stammzelltherapie bei MS. Du findest den vollständigen Blogbeitrag zum Nachlesen unter folgendem Link auf meiner Webseite: https://ms-perspektive.de/223-ectrims-2023-tag-3 Der dritte Tag auf der MS Mailand 2023 bot wieder viele interessante Themen. Dieses Mal habe ich die folgenden ausgewählt: Pädiatrische
2023-11-0242 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2023. Tag 2. Menopause. Wirksamkeit der Behandlung. Immunrekonstitutionstherapie. Gesunder Lebensstil.Wie wirkt die Menopause auf die MS? Wirksamkeit verschiedener Behandlungsalgorithmen inkl. Immunrekonstitutionstherapie. Gesunde Lebensweise. Du findest den vollständigen Artikel zum Nachlesen auf meinem Blog: https://ms-perspektive.de/222-ectrims-2023-tag-2 Der zweite Tag auf der MS Mailand 2023 war wieder vollgepackt mit vielen wertvollen Informationen. Und so viele spannende Vorträge fanden gleichzeitig statt. Ich werde
2023-10-3037 min
RealTalk MSECTRIMS EXTRA: Dr. Robert MotlWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Robert Motl. Dr. Motl is a professor in the department of Kinesiology and Nutrition, and a professor in the department of Rehabilitation Sciences at the University of Illinois Chicago. Dr. Motl is r...
2023-10-2910 min
RealTalk MSECTRIMS EXTRA with Dr. Daniel OntanedaWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Daniel Ontaneda. Dr. Ontaneda is a neurologist at the Cleveland Clinic Neurological Institute's Mellen Center for Multiple Sclerosis and, while attending the ECTRIMS-ACTRIMS meeting, Dr. Ontaneda co-chaired a scientific session on artificial i...
2023-10-2809 min
MS-Perspektive - der Multiple Sklerose Podcast#221: ECTRIMS 2023. 10 Top-Themen und meine Highlights von Tag 1Überblick über die Themen des ECTRIMS 2023. Detaillierter Einblick in die Vision der Heilung von MS, MS und EBV und MS bei älteren Menschen. Du kannst den kompletten Beitrag auf meinem Blog nachlesen: https://ms-perspektive.de/221-ectrims-2023-tag-1 MS Milan 2023 war die 9. gemeinsame Tagung des europäischen ECTRIMS- und des amerikanischen ACTRIMS-Kongresses. Mehr als 8.600 Teilnehmer aus 108 Ländern nahmen teil und hatten die Gelegenheit, 240 Dozenten zuzuhören und die Beiträge von 1.915 Abstracts zu studieren. Es wurden zehn Schwerpunktthemen festgelegt: MS und EBV Screening und Überwachung der Behandlung MS bei älteren Menschen Welcher Biomarker...
2023-10-2726 min
RealTalk MSECTRIMS EXTRA: Dr. Annette Langer-GouldWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Annette Langer-Gould. Dr. Langer-Gould is an MS Specialist at Kaiser-Permanente, and while at the ECTRIMS-ACTRIMS meeting, she co-chaired a session on MS and comorbidities. We have a lot to talk ab...
2023-10-2706 min
RealTalk MSECTRIMS EXTRA with Dr. Anthony FeinsteinWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Anthony Feinstein. Dr. Feinstein is a Professor of Psychiatry at the University of Toronto, and his expertise is in the neuropsychiatry of multiple sclerosis. Dr. Feinstein has studied behavioral disorders in people l...
2023-10-2608 minBeewellwithMS podcast by Dr Agne StraukieneUnlocking Healthy Lifestyle with MS: ECTRIMS 2023 Highlights and Expert InsightsWelcome to 'BeeWellwithMS,' where I, Dr. Agne Straukiene, a neurologist dedicated to enhancing the lives of those with Multiple Sclerosis, dive into the exciting world of MS research. In this episode, I'm thrilled to summarize the groundbreaking presentations from ECTRIMS 2023 by some of the brightest minds in the field.Join me as I break down the insights and discoveries from renowned researchers like Barbara Seebacher, who's exploring the power of music in improving mobility, and Ilana Katz Sand, shedding light on the crucial role of diet and vitamin D.We'll also delve into the world of exercise with insights...
2023-10-2539 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. Day 3. Paediatric MS. Female Health. Prodromic MS. HSCT in MS.Pediatric MS. Female Health. Prodromic MS - can the risk of conversion be reduced? HSCT in MS - new perspectives. You can find the full text to read on my blog: https://ms-perspektive.com/032-ectrims-2023-day-3 The third day at MS Milan 2023 offered again lots of interesting topics. This time I selected the following ones: Paediatric MS Female health Prodromic MS HSCT in MS
2023-10-2531 min
RealTalk MSEpisode 321: More from the 2023 Joint ECTRIMS-ACTRIMS Meeting with Dr. Helen TremlettThis week, we're sharing more from the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. What if we could identify MS before anyone experienced any of the typical clinical symptoms? Would treating that person with a high-efficacy disease-modifying therapy prevent the clinical symptoms of MS from even developing? Those are the questions that make the study of the MS prodrome so fascinating and important. At the joint ECTRIMS-ACTRIMS meeting, I met up with one of the foremost experts on the prodromal...
2023-10-2322 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. Day 2. Menopause. Treatment Efficacy. Immune Reconstitution Therapy. Healthy Lifestyle.Effect of menopause on MS progression? Efficacy of different treatment algorithms incl. immune reconstitution therapy. Healthy lifestyle. You can find the written version to read on my blog: https://ms-perspektive.com/031-ectrims-2023-day-2 The second day at MS Milan 2023 was again packed with lots of valuable information. And so many exciting presentations happened at the sa
2023-10-2328 minNeurologyLive® Mind Moments®2023 ECTRIMS-ACTRIMS Meeting HighlightsWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:
Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.
Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.
Tom Fuchs, MD, Ph...
2023-10-2015 min
RealTalk MSECTRIMS EXTRA with Dr. Jiwon OhWith about 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh. Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital in Toronto, Canada. We have a lot to talk ab...
2023-10-2010 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. 10 Hot Topics and my highlights of day 1Overview on the hot topics of ECTRIMS 2023 and detailed look into the vision of curing MS, MS and EBV and MS in the elderly. you can read the full text with some more details on the statistics of the trials on my blog: https://ms-perspektive.com/030-ectrims-2023-day-1 MS Milan 2023 was the 9th joint meeting of the European ECTRIMS and American ACTRIMS congress. Over 8,600
2023-10-1920 min
RealTalk MSFrom ECTRIMS-ACTRIMS 2023 with Bonnie Higgins and Dr. Tim CoetzeeLast week, more than 9,000 MS research scientists and clinicians from more than 110 countries traveled to Milan to attend the largest MS research conference in the world, the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. In keeping with a RealTalk MS tradition, just as the meeting was ending and the thousands of attendees were heading for the exits, I connected with the National MS Society's Chief Advocacy, Services, and Science Officer, Dr. Tim Coetzee, to discuss some of the research that...
2023-10-1717 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2023 Tag 2, Hellwig & Albrecht | Nervennahrung Podcast ECTRIMS 2023
Dieses Jahr berichten Frau Prof. Hellwig und Herr Prof. Albrecht vom ECTRIMS in Mailand über klinisch-relevante Beiträge aus der Multiplen Sklerose und anderen neuroimmunologischen Erkrankungen.
Die nächste reguläre Episode des Roche Nervennahrung-Podcast erscheint Ende Oktober. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Behandlung von Erkrankungen geht.
Dabei spiegeln die Beiträge den Kenntnisstand unserer...
2023-10-1420 min
MS TalkMS Talk: ECTRIMS 2023
Op 11, 12 en 13 oktober vinden in Milaan de jaarlijkse ECTRIMS plaats. Neuroloog Gerald Hengstman is daarbij aanwezig en maakt speciaal voor deze aflevering contact met Nederland om vanuit Milaan, vers van de pers, te vertellen over de laatste ontwikkelingen op het gebied van MS. Hij praat ons bij over waar er tijdens de ECTRIMS vooral over wordt gesproken en waarover juist niet of veel minder.
Wij bedanken @Gashunters voor de muziek.
2023-10-1318 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2023 Tag 1, Hellwig & Albrecht | Nervennahrung Podcast ECTRIMS 2023
Dieses Jahr berichten Frau Prof. Hellwig und Herr Prof. Albrecht vom ECTRIMS in Mailand über klinisch-relevante Beiträge aus der Multiplen Sklerose und anderen neuroimmunologischen Erkrankungen.
Die nächste Episode des Roche Nervennahrung-Podcast erscheint morgen mit Tag 2 des ECTRIMS. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Behandlung von Erkrankungen geht.
Dabei spiegeln die Beiträge den Kenntnisstand unserer...
2023-10-1319 min
The ECTRIMS PodcastECTRIMS 2022 For People with MS: Part 2Dr. Brigit de Jong from Amsterdam UMC and Professor Alan Thompson from Queens Square Institute of Neurology in London discuss promising, new short-term research data for people with MS unveiled in October during ECTRIMS 2022.
2022-12-2140 min
The ECTRIMS PodcastECTRIMS 2022 For People with MS: Part 1Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.
2022-12-1738 min
RealTalk MSECTRIMS Research Update Part 2 with Dr. Bruce BeboSome of you might remember that at the end of October, I was in Amsterdam, attending the 2022 ECTRIMS Congress. ECTRIMS is an acronym for the European Committee for Treatment and Research in Multiple Sclerosis, and their annual scientific congress is the largest MS research conference in the world. As the conference ended, I sat on some steps outside the conference center alongside the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo. And Dr. Bebo shared his initial impressions of some of the research that had been presented over the 3-day conference. If you missed that episode of...
2022-12-1236 min
The ECTRIMS PodcastThe role of the MS nurse & the need for more globally: an ECTRIMS 2022 recapJoelle Massouh from Harley Street Medical Centre and Piet Eelen from Nationaal MS Centrum talk about the key takeaways of the Nurse Sessions at ECTRIMS 2022, including how the role of the MS nurses has changed over the years, as well as why we need more MS nurses globally and what is being done about it.
2022-11-1627 min
MS News & PerspectivesPoor Myelin Repair Offers Clues in Disease Progression & ECTRIMS and Other MS NewsMultiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression.
He also reads “MS News That Caught My Eye Last Week: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
2022-11-0912 minNeurologyLive® Mind Moments®ECTRIMS 2022 and the Latest in MS AdvancesWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a number of experts in the clinical care of MS who were in attendance at the 2022 ECTRIMS Congress, including Darin T. Okuda, MD, FAAN, FANA, director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center; Federica Picariello, PhD, a health psychologist and postgraduate research associate at King's College London; Brenda Banwell, MD, chief of the Division of Neurology and codirector of the Neuroscience Center at th...
2022-11-0434 min
RealTalk MSFrom the 2022 ECTRIMS Congress with Dr. Bruce BeboLast week, over 7,000 MS researchers and clinicians from more than 100 countries traveled to Amsterdam to attend the 2022 ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress, the largest MS research conference in the world. As has become an annual ECTRIMS tradition on RealTalk MS, the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, and I took up our vantage point on the steps right outside of the convention center to discuss the research that captured Dr. Bebo's attention. We have a lot to talk about! Are you ready for RealTalk MS??!
2022-10-3122 min
MS-SelfieECTRIMS 2022 - highlightsI have just arrived back from ECTRIMS 2022 in Amsterdam and have reflected on a week of meetings. I had little time to view abstracts and/or attend live sessions. I am hoping to catch up with missed content using the on-demand service. Despite this, I managed to get an overview of what is important from discussions with friends and colleagues. 1. EBVEBV remains, in my opinion, on top of the pops. The good news is that almost all of the pharmaceutical companies I spoke to are now including EBV in their long-term thinking. Some companies ar...
2022-10-3121 min
The ECTRIMS PodcastECTRIMS 2022 Wrap-upListen to ECTRIMS President Mar Tintoré wrap up the key takeaways from ECTRIMS 2022, as well as highlight what you can expect from ECTRIMS' new 365 programme.
2022-10-2924 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 3 - Zur Bedeutung früher leichter Schübe, aHSCT und Natalizumab im Vergleich bei Behandlung von progredienter MS und der PROMS Initiative In der 3. Folge vom ECTRIMS 2022 berichte ich von drei Themenblöcken: Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis / Frühe, nicht behindernde Schübe sind bei Menschen mit schubförmig remittierender Multipler Sklerose mit einem höheren Risiko für die Anhäufung von Behinderungen verbunden von Cyrus Daruwalla von der University of Cambridge, Großbritannien Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS / Wirksamkeit der autologen hämatopoetischen Stammzelltransplantation im Vergleich zu Natalizumab bei progredienter MS von Tomas Kalincik von The Royal...
2022-10-2936 min
The ECTRIMS PodcastDay Two Highlights of ECTRIMS 2022Listen to Timothy Coetzee – Chief Advocacy, Services & Science Officer at the National MS Society – discuss the most relevant insights from day two of ECTRIMS 2022.
2022-10-2818 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2022 Tag 2, Mäurer & Meuth | Nervennahrung Podcast ECTRIMS 2022
Die Nervennahrung Neuro News des zweiten Tages des ECTRIMS Kongress 2022 in Amsterdam.
Die Professoren Sven Meuth und Mathias Mäurer berichten täglich vom aktuellen ECTRIMS Kongress in Amsterdam über klinisch-relevante Beiträge aus allen Bereichen der Neurologie.
Die nächste Episode des Roche Nervennahrung-Podcast erscheint nächste Woche, gefolgt von den Neuro News von der Neurowoche Berlin. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also kein...
2022-10-2816 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 2 - Frühe Prognosefaktoren für Behandlungserfolg, Eskalieren und Deeskalieren von Therapien sowie Progrediente MS In der 2. Folge vom ECTRIMS 2022 berichte ich von drei Themenblöcken: Early predictors of treatment outcome / Frühe Prädiktoren für den Behandlungserfolg von Xavier Montalban vom MS Centre of Catalonia Hot Topic 5: Escalating and de-escalating DMTs / Eskalieren und Deeskalieren von verlaufsmodifizierenden Medikamenten Treating active MS following induction therapies / Behandlung der aktiven MS nach Induktionstherapien von Gilles Edan der CHU Renne, Frankreich Long-term stable MS on high-efficacy therapies / Langfristig stabile MS unter hochwirksamen Therapien von Emmanuelle Wubant von der University of California, San Francisco, USA Long-term stable MS on platform therapies / Langfristig stabile MS unter Basi...
2022-10-2755 min
The ECTRIMS PodcastDay One Highlights of ECTRIMS 2022Listen to Brenda Banwell – the ECTRIMS 2022 Keynote Lecturer – deep dive into the key takeaways of the first day of ECTRIMS 2022.
2022-10-2726 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2022 Tag 1, Mäurer & Meuth | Nervennahrung Podcast ECTRIMS 2022
Die Nervennahrung Neuro News des ersten Tages des ECTRIMS Kongress 2022 in Amsterdam.
Die Professoren Sven Meuth und Mathias Mäurer berichten täglich vom aktuellen ECTRIMS Kongress in Amsterdam über klinisch-relevante Beiträge aus allen Bereichen der Neurologie.
Die nächste Episode des Roche Nervennahrung-Podcast Spezials zum ECTRIMS erscheint morgen, am 28.10.2022. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Beha...
2022-10-2714 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 1 - Die Pyramide auf den Kopf stellen und Kindliche MSECTRIMS steht für European Commitee for Treatment and Research in Multiple Sclerosis. Dieses Komitee veranstaltet einen jährlichen Kongress, an dem man mittlerweile auch online teilnehmen kann. Dank meinem Blog, bin ich akkreditierte Pressevertreterin und will Dir punktuelle Einblicke in die dreitägige Veranstaltung vom 26. bis 28.10.2022 geben. Hier geht es zum Blogbeitrag: https://ms-perspektive.de/spezial-ectrims-2022 In dieser Folge habe ich zwei Vorträge gewählt: Flipping the pyramid / Die Pyramide auf den Kopf stellen von Gavin Giovannoni vom Barts and The London School of Medicine and Dentistry, Großbritan...
2022-10-2647 min
MS-SelfieECTRIMS 2022 - initial thoughtsI arrived last night in Amsterdam for this year’s ECTRIMS meeting. Our first real face-to-face meeting of MS researchers and HCPs in three years. I am giving several talks and poster presentations. However, I will spend most of this ECTRIMS having meetings. Yes, this happens at conferences; it is all about networking and is why international travel to conferences will continue despite the large environmental impact.EBVIt is clear that since arriving and speaking to colleagues, the buzz around EBV has not decreased. Saying this, the programme does not include much new work on...
2022-10-2508 minThe ECTRIMS PodcastNEW! The ECTRIMS PodcastWelcome to the ECTRIMS podcast, the new sounding board for the MS research community. Tune in on the 27th, 28th and 29th of October for the official debut of The ECTRIMS Podcast. Enjoy back-to-back episodes of each day of congress, and stay up to date on all the key happenings unfolding at the world's largest international congress for MS research.
2022-10-1701 min
RealTalk MSRe-Visiting Our ECTRIMS 2021 Research Review with Dr. Bruce BeboToday, we're re-visiting my favorite conversation of the entire year and it seems that you and I agree! You've made it this year's most downloaded and listened-to episode. In this episode, Dr. Bruce Bebo, the Executive Vice-President of Research at the National MS Society, briefs us about some of the most interesting and important research shared at ECTRIMS 2021, the largest MS research conference in the world. We have a lot to talk about! Are you ready for RealTalk MS??! Wishing you a happy and healthy new year! :22 ECTRIMS 2021 research...
2021-12-2835 min
RealTalk MSECTRIMS 2021 Research Wrap-Up with Dr. Bruce BeboJust a couple of weeks ago, 9,000 MS research scientists and clinicians from 100 countries gathered virtually for the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis, otherwise known as ECTRIMS. The largest MS research conference in the world lived up to its name, featuring 200 speakers and 1,700 research abstracts. In what has become an annual RealTalk MS tradition, Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, joins us to share his thoughts about the research presented at ECTRIMS that will lead to treatments designed to stop...
2021-11-0134 min
MS PodcastsResearch update: ECTRIMS 2021 highlights with Brett Drummond from MStranslateJoin Nicola Graham as she talks with Brett Drummond, the co-founder of MStranslate. Brett provides a summary of the highlights of ECTRIMs 2021, the largest global congress for MS researchers. Brett shares with us the most exciting and surprising MS research presented. Some topics covered include the latest on re-myelination therapies, COVID and vaccines for people living with MS, Gut Microbiome, Symptom Management and Stem Cell therapies.With thanks to Brett.Reach out for support:MS Plus Connect 1800 042 138 or email connect@msplus.org.auGet in touch to share your comments and suggestions ab...
2021-10-2236 min
MS TalkMS Talk Extra 9: Dag 3 van de Ectrims18 oktober 2021
Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres over MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze laatste aflevering over de Ectrims van 2021 gaat het onder meer over het stoppen met medicatie.
Wij bedanken Hans Geurts van Twoomusic wederom voor de muziek!
2021-10-1814 min
Health Professional Radio - PodcastECTRIMS Virtual Congress 2021 - PONVORY™ In Patients With Relapsing Forms of Multiple SclerosisECTRIMS Virtual Congress 2021 - PONVORY™ In Patients With Relapsing Forms of Multiple Sclerosis by Vertical Internet Media
2021-10-1812 min
MS TalkMS Talk Extra 8: Dag 2 van de Ectrims15 oktober 2021
Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres op basis van MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze aflevering onder andere: er wordt volop onderzoek gedaan naar een nieuw medicijn voor mensen met PPMS en een gezonde leefstijl heeft een positief effect bij MS.
Wij bedanken Hans Geurts van Twoomusic wederom voor de muziek!
2021-10-1511 min
MS TalkMS Talk Extra: dag 1 van de Ectrims 2021Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres op basis van MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze aflevering onder andere: is het zinvol om zo snel mogelijk met hoog effectieve medicijnen MS te gaan behandelen? Wanneer en hoe is een 3e Coronavaccinatie aan te bevelen? Heeft het gebruik van Melatonine een gunstig effect op slaapproblemen bij MS? en een nieuwe manier van behandeling bij het Restless Legs Syndrome.
Wij bedanken Hans Geurts wederom vo...
2021-10-1423 min
RealTalk MSECTRIMS 2019 Research Recap With Dr. Bruce BeboIn this episode of RealTalk MS, we're re-visiting my conversation from ECTRIMS 2019 with Dr. Bruce Bebo, the Executive Vice-President of Research at the National MS Society. This is one of my favorite conversations of the entire year, and you've made it this year's most downloaded and listened to RealTalk MS episode. We're also talking about a new report issued by RAND Europe, entitled Exploring the Societal Burden of Multiple Sclerosis: A Study Into the Non-Clinical Impact of the Disease, Including Changes with Progression. And if you have the RealTalk MS app installed on your iOS or Android s...
2019-12-2729 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day ThreeWelcome to a special episode of RealTalk MS coming to you from Day Three of ECTRIMS 2019 in Stockholm, Sweden. This final day at ECTRIMS has become my favorite day of the conference because it's the day that I get to sit down with Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, and get his perspective on the highlights of the entire conference. We're talking about new Phase 3 clinical trial outcomes, research that shows that lifestyle choices can impact the course and severity of MS, the importance of beginning disease-modifying therapy within 5 years of being...
2019-09-1326 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day TwoWelcome to a special episode of RealTalk MS coming to you from Day Two of ECTRIMS 2019 in Stockholm, Sweden. ECTRIMS is an acronym that stands for the European Conference for Treatment & Research in Multiple Sclerosis, and this annual scientific congress is the largest MS research conference in the world. There are over 9,000 attendees here from more than 100 different countries to share new information, hear research updates, and get face to face with the leading MS researchers in the world. We're talking about stem cell therapy, the long-term outcomes of MS, new data about Ocrevus, the importance of managing comorbidities, and a...
2019-09-1210 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day 1Welcome to a special episode of RealTalk MS coming to you from ECTRIMS 2019 in Stockholm, Sweden. ECTRIMS is an acronym that stands for the European Conference for Treatment & Research in Multiple Sclerosis, and this annual scientific congress is the largest MS research conference in the world. There are over 9,000 attendees here from more than 100 different countries to share new information, hear research updates, and get face to face with the leading MS researchers in the world. We're talking about some of the announcements that we expect to hear from some of the pharmaceutical companies in attendance. And we'll also tell y...
2019-09-1109 min
RealTalk MSECTRIMS 2018 Wrap-UpI'm back from Berlin, Germany, where I attended the 34th annual ECTRIMS Congress, and the single biggest challenge that I faced during the 3-day conference was trying to decide which sessions I wanted to attend. With 80 live presentations, more than 1,000 poster presentations, and any number of meetings and even casual conversations that seem to pop up everywhere, it's challenging trying to take it all in. Although ECTRIMS has ended, there's still a bit more to report from the conference, so please consider this podcast episode as the ECTRIMS wrap-up. We're talking about the effectiveness of a ...
2018-10-1623 min
RealTalk MSLive from Day 3 of ECTRIMS 2018It's the 3rd and final day at ECTRIMS in Berlin! Today, we're taking you to a special documentary screening that we've been keeping under wraps! (You can watch the trailer as part of the "Bonus" content in the RealTalk MS app!) We're talking about the amazing changes in almost every aspect of how we look at MS that have all taken place within just 25 years. We'll walk you through a couple of the scientific sessions that really stood out earlier today. And we'll tell you how you can find scientific victory in the midst of what some...
2018-10-1312 min
RealTalk MSEpisode 58: Live from Day 2 of ECTRIMS 2018It's Day 2 at ECTRIMS in Berlin! Today, we're talking about the Shift.ms booth in the Exhibition Hall, where you can take part in a virtual reality demonstration of what it might be like to accomplish even the simplest tasks if you're living with MS. And if you've downloaded the RealTalk MS app from the Apple App Store for iOS or the Google Play Store for Android, I hope you enjoy the bonus video of the virtual reality demonstration that I shot on the Exhibition Hall floor. I wanted to get an expert's opinion about which ECTRIMS presentations w...
2018-10-1217 min
RealTalk MSLive from Day 1 at ECTRIMS 2018Greetings from Day 1 at ECTRIMS in Berlin! Today, we're talking about pharmaceutical company Novartis seeking approval from the U.S. Food & Drug Administration and the European Medicines Agency for siponimod, a once-daily oral medication that significantly reduces disability progression for people living with secondary progressive MS. This is important news, as 80% of the people living with relapsing remitting MS are eventually diagnosed with secondary progressive MS. And currently, there is no approved disease modifying therapy for secondary progressive MS. The FDA has fast-tracked the approval process, and siponimod could gain the necessary regulatory approval in the U.S. b...
2018-10-1114 min
RealTalk MSOn the Road to ECTRIMSThis week, the European Committee for Treatment and Research in Multiple Sclerosis is hosting the ECTRIMS 2018 Congress in Berlin, Germany. It's the largest MS conference in the world. And you can look forward to special episodes of RealTalk MS direct from ECTRIMS, on Wednesday, Thursday, and Friday, October 10th, 11th, and 12th! You'll get the news, hear the interviews, and you'll be the first to get the research updates and announcements as they're being made at the largest MS conference in the world. And if you have the RealTalk MS app (available free at the Apple App Store and the...
2018-10-0916 min
RealTalk MSECTRIMS 2017 Round-UpLast week, more than 9,000 MS research scientists, physicians, and pharmaceutical industry experts attended ECTRIMS-ACTRIMS, the largest annual international MS research conference in the world. And we're devoting this week's podcast episode to talking about what they were talking about! Welcome to the RealTalk MS ECTRIMS Round-Up! You'll find out about how the "official" number of people with MS in the United States is now more than double what it was before last week. We'll talk about some of the sobering socio-economic effects of MS on women. We'll look at new data from studies on treating Progressive MS, and we'll d...
2017-10-3118 min
Medizin - Open Access LMU - Teil 16/22Review: ‘Gimme five’: future challenges in multiple sclerosis. ECTRIMS Lecture 2009This article is based on the ECTRIMS lecture given at the 25th ECTRIMS meeting which was held in Düsseldorf, Germany, from 9 to 12 September 2009. Five challenges have been identified: (1) safeguarding the principles of medical ethics; (2) optimizing the risk/benefit ratio; (3) bridging the gap between multiple sclerosis and experimental autoimmune encephalitis; (4) promoting neuroprotection and repair; and (5) tailoring multiple sclerosis therapy to the individual patient. Each of these challenges will be discussed and placed in the context of current research into the pathogenesis and treatment of multiple sclerosis.
2010-01-0100 min